Publications Office of the EU
Exclusive drug supply Ravulizumab - EU tenders
DisplayCustomHeader
MyPortal
Language Selector
English
BasketSummary
Procurement Detail Actions Portlet

Utilities

Procurement Detail Actions Portlet
OP Portal - Procurement - Details

This page contains content generated automatically to improve findability and accessibility

- indicates CPV codes deduced from the text of the procedure

- indicates text translated automatically in your browsing language

Exclusive drug supply Ravulizumab

Overview
  • Awarded
    12/08/2026
  • Today
    11/09/2026
Status
Awarded
Type of contract
Supplies
Subject for Renewal
No
Buyer
Hospital Infantil Universitario Niño Jesús
Place of performance
NUTS code: Multiple place of performance
Location of buyer
NUTS code: ES300 Madrid
Business sector (Main CPV)
33600000 Pharmaceutical products
Total estimated contract value (excluding VAT)
Not available
Total final contract value (excluding VAT)
157,770.69 EUR
Procedure details
Tender reference number
A/SUM-017062/2026
Description

Exclusive medicinal product supply Ravulizumab 300mg/3ml concentrate for solution for infusion 1 vial of 3 ml

Submission Method
Not available
Tenders may be submitted
Not available
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
Not available
Place of performance
ES España
ES300 Madrid
CPV code

33600000 - Pharmaceutical products

33690000 - Various medicinal products

Award method
Not available
Estimated value
Not available
Final contracted value
157,770.69 EUR
Award of contract
Official name: ALEXION PHARMA SPAIN, S.L.
Postal address:
Town: BARCELONA
Postal code: 08029
Country:
Documents
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.